HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying Liu Selected Research

RNA Precursors (Precursor, mRNA)

1/2021QKI is a critical pre-mRNA alternative splicing regulator of cardiac myofibrillogenesis and contractile function.
9/2017Targeting cleavage and polyadenylation specific factor 1 via shRNA inhibits cell proliferation in human ovarian cancer.
9/2014Regulation of ubiquitin-proteasome system-mediated Tip110 protein degradation by USP15.
7/2013Tip110 interacts with YB-1 and regulates each other's function.
1/2013Alternative Pre-mRNA Splicing, Cell Death, and Cancer.
4/2012Tip110 maintains expression of pluripotent factors in and pluripotency of human embryonic stem cells.
5/2011TIP110/p110nrb/SART3/p110 regulation of hematopoiesis through CMYC.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying Liu Research Topics

Disease

878Neoplasms (Cancer)
11/2022 - 03/2002
174Infections
09/2022 - 01/2002
168Inflammation (Inflammations)
09/2022 - 08/2002
150Neoplasm Metastasis (Metastasis)
07/2022 - 05/2002
145Breast Neoplasms (Breast Cancer)
06/2022 - 10/2002
79Carcinogenesis
01/2022 - 02/2006
77Hepatocellular Carcinoma (Hepatoma)
12/2022 - 07/2008
76Lung Neoplasms (Lung Cancer)
11/2022 - 12/2002
76Hypoxia (Hypoxemia)
05/2022 - 01/2003
72Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2022 - 12/2002
65Alzheimer Disease (Alzheimer's Disease)
06/2022 - 01/2007
57Fibrosis (Cirrhosis)
09/2022 - 01/2003
53Insulin Resistance
09/2022 - 11/2005
53Stomach Neoplasms (Stomach Cancer)
01/2022 - 03/2004
52Carcinoma (Carcinomatosis)
01/2022 - 03/2002
49Body Weight (Weight, Body)
07/2022 - 07/2003
39Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2007
38Colorectal Neoplasms (Colorectal Cancer)
07/2022 - 01/2006
38Necrosis
04/2022 - 08/2003
38Glioma (Gliomas)
02/2022 - 07/2009
34Liver Neoplasms (Liver Cancer)
12/2022 - 05/2003
34Cardiovascular Diseases (Cardiovascular Disease)
07/2022 - 10/2008
34Hypertension (High Blood Pressure)
01/2022 - 12/2003
34Ischemia
08/2021 - 06/2004
33Ovarian Neoplasms (Ovarian Cancer)
12/2022 - 08/2008
32Pain (Aches)
06/2022 - 03/2011
30Asthma (Bronchial Asthma)
08/2022 - 03/2002
30Parkinson Disease (Parkinson's Disease)
05/2022 - 10/2005
30COVID-19
03/2022 - 01/2020
30Wounds and Injuries (Trauma)
01/2022 - 02/2005
29Squamous Cell Carcinoma of Head and Neck
03/2022 - 11/2011
29Cognitive Dysfunction
01/2022 - 10/2004
28Obesity
07/2022 - 11/2007
28Atherosclerosis
03/2021 - 08/2005
26Esophageal Squamous Cell Carcinoma
09/2022 - 01/2009
26Chronic Hepatitis B
06/2021 - 07/2006
25Lymphatic Metastasis
06/2022 - 12/2007
25Reperfusion Injury
03/2022 - 04/2009
25Prostatic Neoplasms (Prostate Cancer)
01/2022 - 09/2009
25Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2021 - 07/2007
24Heart Failure
10/2022 - 06/2005
24Stroke (Strokes)
06/2022 - 02/2011
24Myocardial Infarction
01/2022 - 01/2004
23Adenocarcinoma of Lung
01/2022 - 01/2015
22Pneumonia (Pneumonitis)
04/2022 - 01/2013
22Hepatitis B
01/2022 - 06/2004
20Hemorrhage
09/2022 - 10/2003
20Adenocarcinoma
07/2022 - 03/2002
20Brain Ischemia (Cerebral Ischemia)
03/2022 - 09/2003

Drug/Important Bio-Agent (IBA)

315Proteins (Proteins, Gene)FDA Link
07/2022 - 04/2002
163Biomarkers (Surrogate Marker)IBA
05/2022 - 03/2006
150Pharmaceutical PreparationsIBA
11/2022 - 12/2003
101MicroRNAs (MicroRNA)IBA
05/2022 - 10/2010
88Messenger RNA (mRNA)IBA
04/2022 - 03/2003
81Biological ProductsIBA
05/2022 - 12/2002
77Glucose (Dextrose)FDA LinkGeneric
09/2022 - 11/2005
77CytokinesIBA
04/2022 - 01/2005
73LipidsIBA
02/2022 - 09/2003
58EnzymesIBA
04/2022 - 08/2003
57DNA (Deoxyribonucleic Acid)IBA
03/2022 - 04/2002
47Long Noncoding RNAIBA
06/2022 - 03/2014
46VaccinesIBA
11/2022 - 04/2004
45Cisplatin (Platino)FDA LinkGeneric
06/2022 - 03/2003
45Insulin (Novolin)FDA Link
04/2022 - 05/2007
40Small Interfering RNA (siRNA)IBA
02/2022 - 04/2004
39Reactive Oxygen Species (Oxygen Radicals)IBA
07/2022 - 01/2003
38Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2022 - 02/2004
36Peptides (Polypeptides)IBA
12/2022 - 04/2004
36Interleukin-6 (Interleukin 6)IBA
07/2022 - 04/2012
35AntigensIBA
07/2022 - 04/2004
34Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 03/2003
32RNA (Ribonucleic Acid)IBA
05/2022 - 12/2006
32Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2022 - 06/2004
32LigandsIBA
01/2022 - 08/2002
30Paclitaxel (Taxol)FDA LinkGeneric
12/2022 - 01/2010
30CholesterolIBA
10/2022 - 02/2004
29Antiviral Agents (Antivirals)IBA
01/2022 - 09/2006
28Anti-Bacterial Agents (Antibiotics)IBA
06/2022 - 04/2007
27Indicators and Reagents (Reagents)IBA
12/2022 - 11/2002
27Therapeutic UsesIBA
01/2022 - 05/2005
27ErbB Receptors (EGF Receptor)IBA
12/2021 - 02/2006
26Oxygen (Dioxygen)IBA
05/2022 - 01/2003
26Circular RNAIBA
03/2022 - 01/2019
25Fluorouracil (Carac)FDA LinkGeneric
11/2022 - 04/2004
25CollagenIBA
04/2022 - 01/2002
24Phosphotransferases (Kinase)IBA
06/2022 - 11/2002
24AntioxidantsIBA
01/2022 - 03/2007
23InterferonsIBA
01/2021 - 12/2005
21Caspase 3 (Caspase-3)IBA
03/2022 - 08/2014
21Transcription Factors (Transcription Factor)IBA
03/2022 - 01/2003
20Hormones (Hormone)IBA
07/2022 - 11/2005
20Polysaccharides (Glycans)IBA
06/2022 - 08/2006

Therapy/Procedure

404Therapeutics
12/2022 - 12/2002
140Drug Therapy (Chemotherapy)
12/2022 - 01/2002
49Radiotherapy
06/2022 - 05/2002
36Immunotherapy
07/2022 - 04/2004
30Liver Transplantation
06/2022 - 12/2014
24Transplantation
04/2022 - 08/2003
23Aftercare (After-Treatment)
05/2022 - 03/2003
22Chinese Traditional Medicine (Traditional Chinese Medicine)
11/2022 - 10/2006